Earnings History Data for Fluidigm Corporation (FLDM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Fluidigm Corporation

Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit (IFC); TOPAZ system for protein crystallography; Dynamic Array integrated fluidic circuits (IFCs); and Access Array Assay Design Services. The Company's products find its application in Gene Expression, Single-Cell Gene Expression, SNP Genotyping, Targeted Resequencing, Sample Quantitation, Copy Number Variation and Protein Crystallization. Fluidigm Corporation is based in San Francisco, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
17-02-2022	AH		FLDM	Fluidigm Corporation	269.99	-0.06	0.00	-0.18	Fluidigm Non-GAAP EPS of -$0.01 beats by $0.17, revenue of $38.27M beats by $5.57M [2/17/2022 6:01 PM]	3.61	0.25 (7.29%)	3.45	0.09 (2.68%)	2.67 - 7.51	820,834	1,150,000	1,172
Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies [Feb-17-22 08:30AM] Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results [Feb-17-22 05:43PM]
08-11-2021	AH	4:05 PM ET (Nov 8)	FLDM	Fluidigm Corporation	383.12	-0.13	0.00	-0.03	Fluidigm EPS beats by $0.04, misses on revenue [11/8/2021 4:12 PM]	4.61	-0.21 (-4.36%)	4.56	-0.26 (-5.39%)	3.71 - 7.51	962,150	550,000	27,945
Fluidigm EPS beats by $0.04, misses on revenue [11/8/2021 4:12 PM] Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate Cancer [Nov-08-21 08:30AM] Fluidigm Announces Third Quarter 2021 Financial Results [Nov-08-21 04:02PM] Fluidigm Q3 Sales Trail Estimates; Cuts Annual Guidance As COVID-19 Sales Retreat [Nov-09-21 08:11AM]
05-08-2021	AH	4:05 PM ET (Aug 5)	FLDM	Fluidigm Corporation	524.74	-0.17	-0.15	-0.12	Fluidigm EPS misses by $0.03, revenue in-line [8/5/2021 4:45 PM]	6.39	-0.44 (-6.44%)	6.40	-0.43 (-6.30%)	3.71 - 12.45	840,629	1,410,000	8,120
Fluidigm Announces Collaboration Agreement with Imaging CRO ImaBiotech to Increase Biopharma Access to Imaging Mass Cytometry [Aug-05-21 08:35AM] Fluidigm Announces Co-Marketing Agreement with Ultivue for Biomarker Imaging Solutions for Precision Medicine [Aug-05-21 08:30AM] Ultivue Announces Co-Marketing Agreement with Fluidigm for Biomarker Imaging Solutions for Precision Medicine [Aug-05-21 09:30AM] Fluidigm Announces Second Quarter 2021 Financial Results with Total Revenue of $31.0 Million [Aug-05-21 04:05PM]
06-05-2021	AH	4:05 PM ET (May 6)	FLDM	Fluidigm Corporation	380.81	-0.20	-0.06	-0.16	Fluidigm EPS misses by $0.11, beats on revenue [5/6/2021 4:31 PM]	5.13	0.54 (11.76%)	4.25	-0.34 (-7.41%)	3.33 - 12.45	3,020,063	1,510,000	543,503
Fluidigm EPS misses by $0.11, beats on revenue [5/6/2021 4:31 PM] Data Published in Nature Communications Demonstrate the Power of Fluidigms CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approaches in Clinical Oncology [May-06-21 08:30AM] Fluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year Period [May-06-21 04:05PM]
10-02-2021	AH	4:05 PM ET (Feb 10)	FLDM	Fluidigm Corporation	516.98	-0.18	-0.09	-0.07	Fluidigm EPS misses by $0.14, misses on revenue [2/10/2021 4:11 PM]	5.62	-1.48 (-20.80%)	5.88	-1.21 (-17.07%)	1.17 - 12.45	10,995,707	2,510,870	469,739
Fluidigm EPS misses by $0.14, misses on revenue [2/10/2021 4:11 PM] Fluidigm inks supply and distribution deal with Zhejiang PuLuoTing Health [2/10/2021 4:18 PM] The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts [Feb-11-21 07:26AM] Fluidigm Corp. to Host Earnings Call [Feb-10-21 02:45PM]
05-11-2020	AH	4:05 PM ET (Nov 5)	FLDM	Fluidigm Corporation	476.72	-0.03	-0.10	-0.14	Fluidigm EPS beats by $0.12, beats on revenue [11/5/2020 6:02 PM]	7.59	0.79 (11.62%)	6.90	0.10 (1.47%)	1.17 - 12.45	4,211,954	1,711,531	55,064

06-08-2020	AH	4:05 PM ET (Aug 6)	FLDM	Fluidigm Corporation	495.65	-0.12	-0.15	-0.15	Fluidigm EPS beats by $0.07, beats on revenue [8/6/2020 4:09 PM]	7.38	0.59 (8.70%)	7.30	0.52 (7.59%)	1.17 - 9.26	2,216,260	8,351,533	59,091